A medication commonly prescribed for chronic back pain is now drawing growing attention from researchers after a major new study suggested it may be associated with an increased risk of dementia and cognitive decline.
The drug, gabapentin, has been used for decades and is often considered a safer alternative to opioid painkillers. Millions of people take it for nerve pain, chronic back pain, restless legs syndrome, and other long-term conditions.
But according to new findings from researchers at Case Western Reserve University and collaborating institutions, long-term use may come with cognitive risks that patients and doctors should carefully consider.
Researchers Compared More Than 26,000 Adults
The research team analyzed medical records from 68 health systems across the United States.
They compared:
- 26,414 adults who were prescribed gabapentin for chronic low-back pain
- with a matched group of adults who had similar pain conditions but did not take the medication.
The researchers then followed patients for up to 10 years to evaluate rates of dementia and mild cognitive impairment (MCI).
The Results Raised Concern
The findings showed a significant association between repeated gabapentin prescriptions and later cognitive decline.
Adults who received six or more gabapentin prescriptions were:
- 29% more likely to develop dementia
- 85% more likely to develop mild cognitive impairment (MCI)
Mild cognitive impairment refers to noticeable memory or thinking problems that are greater than normal aging but not severe enough to interfere heavily with daily life.
Researchers noted that MCI can sometimes progress to dementia over time.
Younger Adults Showed Surprisingly High Risk
One of the most unexpected findings involved middle-aged adults rather than seniors.
Among adults ages 35–49:
- dementia risk more than doubled,
- and MCI risk more than tripled.
Adults ages 50–64 also showed elevated risk levels.
Interestingly, researchers did not observe increased dementia risk among adults aged 18–34.
More Prescriptions Appeared to Increase Risk
The study found what researchers described as a “dose-response relationship.”
In simple terms, people who received more prescriptions appeared to face greater cognitive risk.
Among adults with 12 or more prescriptions:
- dementia risk increased by 40%,
- and MCI risk increased by 65%.
The pattern remained even after researchers adjusted for:
- age,
- other medical conditions,
- medication use,
- and demographic factors.
What Is Gabapentin?
Gabapentin was originally approved in the 1990s as a treatment for epilepsy.
Over time, doctors increasingly prescribed it for:
- nerve pain,
- chronic back pain,
- post-shingles pain,
- fibromyalgia,
- and restless legs syndrome.
Because it is not an opioid, gabapentin became especially popular during efforts to reduce opioid prescribing.
Many patients take the drug for months or even years.
Common Side Effects Already Associated With Gabapentin
Like many medications affecting the nervous system, gabapentin already carries known side effects.
Commonly Reported Effects Include:
- drowsiness,
- dizziness,
- fatigue,
- swelling in the limbs,
- dry mouth,
- difficulty concentrating.
Earlier research has also raised concerns about breathing problems in some patients, especially when combined with other sedating medications.
Does This Study Prove Gabapentin Causes Dementia?
No.
The researchers emphasized that this was an observational study, meaning it identified a strong association but did not prove direct causation.
That distinction matters.
Observational studies can show patterns and possible risks, but they cannot fully determine whether a medication directly caused the outcome.
Why the Findings Still Matter
Even though the study cannot prove cause and effect, experts say the findings deserve attention for several reasons:
- the study involved a very large population,
- the cognitive risk appeared dose-related,
- the findings remained after statistical adjustments,
- and similar concerns have appeared in previous research.
Researchers also attempted to account for factors like reduced mobility and chronic pain severity, both of which can themselves increase dementia risk.
Because the comparison group had similar back-pain conditions but did not use gabapentin, mobility problems alone likely do not fully explain the difference.
Why Chronic Pain and Dementia Can Be Connected
It is important to understand that chronic pain itself may affect brain health.
Long-term pain has been associated with:
- sleep disruption,
- stress hormone changes,
- reduced physical activity,
- social isolation,
- and inflammation.
All of these may contribute to cognitive decline over time.
This makes studying pain medications especially complex.
What Patients Should Do
Experts strongly caution patients against suddenly stopping gabapentin without medical guidance.
Stopping the medication abruptly may cause:
- withdrawal symptoms,
- increased pain,
- anxiety,
- sleep problems,
- and, in some cases, seizures.
Instead, the study highlights the importance of informed conversations between patients and healthcare providers.
Questions Patients May Want to Discuss With Their Doctor
- Is gabapentin still the best option for my condition?
- Am I taking the lowest effective dose?
- Could alternative therapies help reduce long-term use?
- Should my cognitive function be monitored over time?
- Are there lifestyle changes that may help manage my pain naturally?
Lifestyle Factors That May Support Brain and Nerve Health
Although no lifestyle habit guarantees dementia prevention, research consistently supports several protective behaviors:
- regular physical activity,
- quality sleep,
- social interaction,
- blood pressure management,
- balanced nutrition,
- mental stimulation,
- avoiding smoking.
For chronic pain specifically, some patients may benefit from combining medical treatment with:
- physical therapy,
- gentle exercise,
- stress management,
- weight management,
- and ergonomic changes.
The Bigger Picture
Gabapentin remains an important medication for many patients and may significantly improve quality of life when used appropriately.
However, the new findings add to growing discussions about how long-term medications may influence brain health over time.
Researchers say additional studies are needed to better understand:
- whether gabapentin directly contributes to dementia risk,
- how dosage influences long-term outcomes,
- and which patients may be most vulnerable.
Final Thoughts
The study does not mean that everyone taking gabapentin will develop dementia.
But it does reinforce an important principle in medicine: every treatment carries potential benefits and risks.
For patients living with chronic pain, informed decision-making and regular medical follow-up remain essential.
Awareness, monitoring, and open conversations with healthcare providers may help patients make safer long-term choices while still managing pain effectively.
This article is for informational purposes only and should not replace professional medical advice, diagnosis, or treatment.
.jpg)
.png)
0 commentaires:
Enregistrer un commentaire